Kenney Richard T 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Apr 1, 2021
Insider Transaction Report
Form 4
Kenney Richard T
Chief Medical Officer
Transactions
- Award
Common Stock
2021-03-25+25,000→ 25,000 total
Footnotes (1)
- [F1]On March 25, 2021, the Reporting Person was granted 25,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on March 25, 2022 and 50% of the restricted stock units on March 25, 2023.